159 related articles for article (PubMed ID: 32099860)
1. Relationship between Vitamin D levels and pain and disease activity in patients with newly diagnosed axial spondyloarthritis.
Deng S; He Y; Nian X; Sun E; Li L
Int J Nurs Sci; 2020 Jan; 7(1):54-59. PubMed ID: 32099860
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Deficiency in Axial Spondyloarthritis is Associated With Higher Disease Activity.
Zhao SZ; Thong D; Duffield S; Goodson N
Arch Rheumatol; 2017 Sep; 32(3):209-215. PubMed ID: 30375524
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
4. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
5. Activated coagulation is associated with the disease activity of axial spondyloarthritis.
Li Y; Zhang Y; Xu W; Liang J; Luo X; Han X; Shi X; Jie H; Li X; He Y; Sun E
Int Immunopharmacol; 2020 Nov; 88():106979. PubMed ID: 33182036
[TBL] [Abstract][Full Text] [Related]
6. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
[TBL] [Abstract][Full Text] [Related]
7. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis.
Kilic G; Kilic E; Ozgocmen S
Medicine (Baltimore); 2014 Dec; 93(29):e337. PubMed ID: 25546683
[TBL] [Abstract][Full Text] [Related]
8. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore.
Hong C; Kwan YH; Leung YY; Lui NL; Fong W
Int J Rheum Dis; 2019 Aug; 22(8):1506-1511. PubMed ID: 31090201
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D serum concentration is not related to the activity of spondyloarthritis - preliminary study.
Guła Z; Kopczyńska A; Hańska K; Słomski M; Nowakowski J; Kwaśny-Krochin B; Gąsowski J; Korkosz M
Reumatologia; 2018; 56(6):388-391. PubMed ID: 30647486
[TBL] [Abstract][Full Text] [Related]
11. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
[TBL] [Abstract][Full Text] [Related]
12. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
13. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
Kilic G; Kilic E; Ozgocmen S
Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
[TBL] [Abstract][Full Text] [Related]
14. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
[TBL] [Abstract][Full Text] [Related]
15. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
[TBL] [Abstract][Full Text] [Related]
16. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
17. Correlation between C-Reactive Protein to Albumin Ratio and Disease Activity in Patients with Axial Spondyloarthritis.
Zhong Z; Huang Y; Liu Y; Chen J; Liu M; Huang Q; Zheng S; Guo X; Deng W; Li T
Dis Markers; 2021; 2021():6642486. PubMed ID: 34234877
[TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Levels of Sclerostin are Associated with High Disease Activity and Functional Impairment in Patients with Axial Spondyloarthritis.
Muntean L; Lungu A; Gheorghe SR; Valeanu M; Craciun AM; Felea I; Petcu A; Filipescu I; Simon SP; Rednic S
Clin Lab; 2016; 62(4):589-97. PubMed ID: 27215077
[TBL] [Abstract][Full Text] [Related]
19. Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort.
Mogard E; Olofsson T; Bergman S; Bremander A; Kristensen LE; Olsen JK; Wallman JK; Lindqvist E
J Rheumatol; 2021 Nov; 48(11):1672-1679. PubMed ID: 33323532
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.
Landewé R; Braun J; Deodhar A; Dougados M; Maksymowych WP; Mease PJ; Reveille JD; Rudwaleit M; van der Heijde D; Stach C; Hoepken B; Fichtner A; Coteur G; de Longueville M; Sieper J
Ann Rheum Dis; 2014 Jan; 73(1):39-47. PubMed ID: 24013647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]